Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 701–800 of 1,062
Lipid metabolism in peroxisomes in relation to human disease
Wanders, R. J. A., & Tager, J. M. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(98)00003-x · Cited by 122
Liu, C., Ma, J., & Sun, Y.-Z. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.09.007 · Cited by 122
Koyutürk, M., Ersöz, M., & Altıok, N. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.009 · Cited by 142
Hinson, D. D., Chambliss, K. L., Toth, M. J., Tanaka, R. D., & Gibson, K. M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34935-x · Cited by 122
Ciftci, M., Simsek, U. G., Yuce, A., Yilmaz, O., & Dalkilic, B. (2010) · Acta Veterinaria Brno · doi:10.2754/avb201079010033 · Cited by 122
“The cholesterol lowering property of essential oil constituents has been ascribed to suppressing of 3-hydroxy-3-methylglutaryl coenzyme A reductase (Elson et al. 1989), the enzyme that is considered to be rate limiting in cholesterol synthesis (Goldstein and Brown 1990).”
BackgroundWächtershäuser, A., Akoglu, B., & Stein, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1061 · Cited by 123
“, 38, 45–50. for the chemoprevention and/or the non-toxic treatment of 20. Wachtershauser,A., Loitsch,S.M. and Stein,J. (2000) PPAR-γ is selectively colon carcinogenesis.”
BackgroundAoyama, T., Fujiwara, H., Masaki, Τ., & Sawamura, T. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1041 · Cited by 122
Li, C., Yang, C. W., Park, J. H., Lim, S. W., Sun, B., Jung, J., Kim, S. B., Kim, Y., Kim, J., & Bang, B. K. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00428.2002 · Cited by 123
“Statins are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the key enzyme that regulates the synthesis of cholesterol from mevalonic acid by suppressing the conversion of HMG-CoA (13).”
InfluentialExpression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity
Allen, S. P., Khan, S., Tam, S., Koschinsky, M. L., Taylor, P. M., & Yacoub, M. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1765 · Cited by 135
“It has been demonstrated that lipoprotein depletion of cells ( 27 , 28) as well as treatment of cells with 3-hydroxy-3methyglutaryl-coenzyme A reductase inhibitors (statins) (28, 29) results in up-regulation of the LDL receptor.”
BackgroundSerum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
Eliassen, A. H., Colditz, G. A., ROSNER, B. A., Willett, W. C., & Hankinson, S. E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.19.2264 · Cited by 133
“This pathway not only leads to the production of cholesterol but also includes intermediate products that are essential to cell cycle progression.(55,56) Statins have inhibited tumor growth in murine models of brain, pancreatic, and breast cancer(57-59) and have induced apoptosis in leukemic, colon cancer, and breast…”
BackgroundMutations in NPC1 Highlight a Conserved NPC1-Specific Cysteine-Rich Domain
Greer, W. L., Dobson, M. J., Girouard, G., Byers, D., Riddell, D. C., & Neumann, P. E. (1999) · The American Journal of Human Genetics · doi:10.1086/302620 · Cited by 121
“Higher cholesterol levels increase the susceptibility of HMG-CoA reductase, a key enzyme in the sterol biosynthetic pathway, to proteolysis (Goldstein and Brown 1990), whereas lower cholesterol levels trigger activation of SCAP, which leads to proteolytic release of the transcription factors…”
BackgroundBiochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome
Waterham, H. R., & Wanders, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00159-1 · Cited by 138
Miquel, K., Pradines, A., Tercé, F., Selmi, S., & Favre, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26179 · Cited by 126
Clustering of cardiovascular risk factors: Targeting high-risk individuals
Genest, J. J., & Cohn, J. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80010-4 · Cited by 124
Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice
Hosoi, T., Yokoyama, S., Matsuo, S., Akira, S., & Ozawa, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012537 · Cited by 120
“tional level of HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis [19], was up-regulated in the liver sample of MyD88-deficient mice fed the HFD (Figure 5E).”
BackgroundBagheri, H., Ghasemi, F., Barreto, G. E., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1597 · Cited by 127
“These attachments facilitate them to anchor to the cell membranes to manifest their regular functions.(8,9) Despite of the therapeutic effects of statins, they have also potential adverse and side effects including increasing the risk of diabetes mellitus (except pitavastatin), myopathy/myalgia (most frequent side eff…”
BackgroundGiacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 133
Insulin-induced gene: A new regulator in lipid metabolism
Dong, X., & Tang, S.-Q. (2010) · Peptides · doi:10.1016/j.peptides.2010.07.020 · Cited by 136
Yoshida, Y., Saito, Y., Jones, L. S., & Shigeri, Y. (2007) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.104.439 · Cited by 122
Denoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 128
Isoprenoids Control Germ Cell Migration Downstream of HMGCoA Reductase
SANTOS, A. C. D. S., & Lehmann, R. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00023-1 · Cited by 118
Therapy Insight: potential of statins for cancer chemoprevention and therapy
Katz, M. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0097 · Cited by 129
“Although early research focused on the Ras family of oncogenes”
BackgroundYamashita, M., Otsuka, F., Mukai, T., Otani, H., Inagaki, K., Miyoshi, T., Goto, J., Yamamura, M., & Makino, H. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0532 · Cited by 138
“Statins inhibit 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase to block the conversion of HMG-CoA to mevalonate, a rate-limiting step in cholesterol synthesis (Goldstein & Brown 1990).”
Organization of the bovine gene encoding the endothelial nitric oxide synthase
Venema, R. C., Nishida, K., Alexander, R. W., Harrison, D. G., & Murphy, T. J. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90195-3 · Cited by 121
LAGACE, T. A., BYERS, D. M., COOK, H. W., & RIDGWAY, N. D. (1997) · Biochemical Journal · doi:10.1042/bj3260205 · Cited by 120
Microbial Isoprenoid Production: An Example of Green Chemistry through Metabolic Engineering
Maury, J., Asadollahi, M. A., Møller, K., Clark, A., & Nielsen, J. (2005) · Advances in biochemical engineering, biotechnology · doi:10.1007/b136410 · Cited by 138
Göbel, A., Breining, D., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1322-x · Cited by 125
A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications
Suazo, K. F., Park, K., & Distefano, M. D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01108 · Cited by 126
Mallinson, J. E., Constantin‐Teodosiu, D., Sidaway, J., Westwood, F. R., & Greenhaff, P. L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164699 · Cited by 120
“Prenylated proteins, or GTPases, are downstream intermediary metabolites of cholesterol synthesis and inhibition of HMG-CoA reductase by statins reduces the prenylation, and hence activation, of many GTPases (Goldstein & Brown, 1990).”
BackgroundMetz, S. A., Rabaglia, M. E., Stock, J. B., & Kowluru, A. (1993) · Biochemical Journal · doi:10.1042/bj2950031 · Cited by 119
Li, C., Briggs, M. R., Ahlborn, T. E., Kraemer, F. B., & Liu, J. (2001) · Endocrinology · doi:10.1210/endo.142.4.8096 · Cited by 137
Lange, B. M., & Croteau, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13714 · Cited by 119
Kohtz, J. D., Lee, H. Y., Gaiano, N., Segal, J., Ng, E., Larson, T., Baker, D. P., Garber, E. A., Williams, K. P., & Fishell, G. (2001) · Development · doi:10.1242/dev.128.12.2351 · Cited by 122
Cholesterol homeostasis. Modulation by amphiphiles.
Lange, Y., & Steck, T. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43886-0 · Cited by 121
Protein prenyl transferase activities of Plasmodium falciparum
Chakrabarti, D., Azam, T., DELVECCHIO, C., Qiu, L., Park, Y. I., & Allen, C. M. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(98)00065-6 · Cited by 119
“gave early evidence to support the hypothesis that prenylated proteins are involved in the regulation of cell growth [6–8].”
BackgroundResultSU, P., RENNERT, H., SHAYIQ, R. M., YAMAMOTO, R., ZHENG, Y.-M., ADDYA, S., STRAUSS, J. F., & AVADHANI, N. G. (1990) · DNA and Cell Biology · doi:10.1089/dna.1990.9.657 · Cited by 120
“The increase in P450c26/25 mRNA observed in the present study in response to gonadotropins is of interest in view of the notion that 26-hydroxycholesterol is an endogenous inhibitor of de novo cholesterol synthesis and LDL receptor gene expression (Goldstein and Brown, 1990).”
Qureshi, A. A., Sami, S. A., Salser, W. A., & Khan, F. A. (2001) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(01)00144-9 · Cited by 118
Mutational spectrum and genotype–phenotype correlations in mevalonate kinase deficiency
Mandey, S. H. L., Schneiders, M. S., Koster, J., & Waterham, H. R. (2006) · Human Mutation · doi:10.1002/humu.20361 · Cited by 118
Jeon, T.-I., Esquejo, R. M., Roqueta-Rivera, M., Phelan, P. E., Moon, Y.-A., Govindarajan, S. S., Esau, C. C., & Osborne, T. F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.010 · Cited by 118
“Because intracellular Ch levels are tightly controlled (Goldstein and Brown, 1990), we reasoned that additional miRNAs might be involved in regulating intracellular Ch, possibly being more robustly activated by SREBPs than miR-33 and having unique target genes involved 52 Cell Metabolism 18, 51–61,…”
BackgroundTargeting Trypanosoma cruzi Sterol 14α-Demethylase (CYP51)
Lepesheva, G. I., Villalta, F., & Waterman, M. R. (2011) · Advances in Parasitology/Advances in parasitology · doi:10.1016/b978-0-12-385863-4.00004-6 · Cited by 121
Giusti‐Paiva, A., Martinez, M. R., Félix, J. V. C., Rocha, M. J. A., Cárnio, E. C., Elias, L. L. K., & Antunes‐Rodrigues, J. (2004) · Shock · doi:10.1097/10.shk.0000115756.74059.ce · Cited by 118
“HMG-CoA reductase inhibitor interrupts the isoprenylation of small G proteins (e.g., Ras and Rho) by decreasing FPP and GGPP level, leading to the accumulation of inactive small G proteins in the cytoplasm.”
BackgroundAnticoagulant effects of statins and their clinical implications
Brummel‐Ziedins, K. E., Mann, K. G., & Undas, A. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0720 · Cited by 124
“Statins reduce formation of isoprenoids, altering protein prenylation, a critical event in the posttranslational modification of proteins involved in the regulation of cell cycle progression, proliferation and signalling pathways (7, 8).”
BackgroundShibata, M., Ito, Y., Morimoto, J., & Otsuki, Y. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh201 · Cited by 127
Yamada, S., Ohira, M., Horie, H., Ando, K., Takayasu, H., Suzuki, Y., Sugano, S., Hirata, T., Goto, T., Matsunaga, T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207782 · Cited by 120
“The LDL receptor 1 binds LDL, a major plasma cholesterolcarrying lipoprotein, and plays an important role in cholesterol homeostasis (Sudhof et al., 1987; Goldstein and Brown, 1990; Hamanaka et al., 1992).”
BackgroundSqualene synthase: a critical enzyme in the cholesterol biosynthesis pathway
Do, R., Kiss, R., Gaudet, D., & Engert, J. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01099.x · Cited by 120
“Products of the non-sterol branch are involved in key cellular processes, such as mRNA translation (isopentenyl adenosine), protein glycosylation (dolichol), oxidative phosphorylation (heme A and ubiquinone), signal transduction (farnesylated proteins such as Ras and lamin B) and geranylgeranylated proteins such as Ra…”
BackgroundRidsdale, A., Denis, M., Gougeon, P.-Y., Ngsee, J. K., Presley, J. F., & Zha, X. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0100 · Cited by 113
“Mevalonate is also a precursor of isoprenoid intermediates (Goldstein and Brown, 1990), which are required for posttranslational modifications of many proteins, including small G proteins, such as these in the Ras and Rho families (Van Aelst and D’Souza-Schorey, 1997).”
BackgroundOxysterol-induced Apoptosis in Human Monocytic Cell Lines
Aupeix, K., Weltin, D., Mejía, J. E., Christ, M., Marchal, J., Freyssinet, J., & Bischoff, P. L. (1995) · Immunobiology · doi:10.1016/s0171-2985(11)80108-7 · Cited by 118
The intracellular targeting and membrane topology of 3-hydroxy-3-methylglutaryl-CoA reductase.
Olender, E. H., & Simon, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50651-2 · Cited by 118
Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
Tousoulis, D., Simopoulou, C., Παπαγεωργίου, Ν., Oikonomou, E. K., Hatzis, G., Siasos, G., Tsiamis, E. G., & Stefanadis, C. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.003 · Cited by 133
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
Pinkosky, S. L., Groot, P. H. E., Lalwani, N. D., & Steinberg, G. R. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.09.001 · Cited by 126
Ubiquinone: cholesterol's reclusive cousin
Hargreaves, I. P. (2003) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456303321610493 · Cited by 118
A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1
Nadav, E., Shmueli, A., Barr, H. M., Gonen, H., Ciechanover, A. J., & Reiss, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00279-1 · Cited by 117
“When cells are deprived of cholesterol, HMGR is stabilized and its level is high, but when cholesterol is abundant HMGR is rapidly degraded and its level decreases [ 8 ].”
BackgroundSchmidmaier, R., Baumann, P., Simsek, M., Dayyani, F., Emmerich, B., & Meinhardt, G. (2004) · Blood · doi:10.1182/blood-2003-12-4218 · Cited by 118
Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages
Fuhrman, B., Volkova, N., & Aviram, M. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.02.009 · Cited by 129
Statins and their role in vascular protection
Mason, J. C. (2003) · Clinical Science · doi:10.1042/cs20030148 · Cited by 126
Dabrah, T. T., HARWOOD, H. J., HUANG, L. H., JANKOVICH, N. D., Kaneko, T., LI, J.-C., Lindsey, S., MOSHIER, P. M., Subashi, T. A., Therrien, M., et al. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.1 · Cited by 117
Caveolae and intracellular trafficking of cholesterol
Fielding, C. J., & Fielding, P. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00140-5 · Cited by 116
Brusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P., Guan, G., Shechter, I., Claessens, F., Verhoeven, G., & Swinnen, J. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611763200 · Cited by 116
Yazawa, H., Zimmermann, B., Asami, Y., & Bernimoulin, J. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.2.295 · Cited by 116
García-Ruiz, C., Baulies, A., Mari, M., García-Rovés, P. M., & Fernandez-Checa, J. C. (2013) · Free Radical Research · doi:10.3109/10715762.2013.830717 · Cited by 119
Nakahara, K., Kuriyama, M., Sonoda, Y., Yoshidome, H., Nakagawa, H., Fujiyama, J., Higuchi, I., & Osame, M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8491 · Cited by 126
Structural genomics of enzymes involved in sterol/isoprenoid biosynthesis
Bonanno, J. B., Edo, C., Eswar, N., Pieper, U., Romanowski, M. J., Ilyin, V., Gerchman, S. E., Kycia, H., Studier, F. W., Šali, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181466998 · Cited by 124
Gardner, R. G., Shearer, A. G., & Hampton, R. Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4276-4291.2001 · Cited by 116
“These studies have mechanistic implications for understanding both the specificity of quality control degradation and the clinically relevant axis of sterol regulation that employs ERAD to control the cellular synthesis of cholesterol (29).”
BackgroundLuo, J., Zhang, W., Zhang, G., Guan, J., & Chen, X. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03165.x · Cited by 116
“Mevalonic acid, an intracellular product of HMG-CoA reductase, is necessary for cell growth.(8) Mevalonate metabolism yields a series of isoprenoid derivatives that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control.”
BackgroundRegulation of fatty acid oxidation in mammalian liver
Guzmán, M., & Geelen, M. J. H. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90224-w · Cited by 127
Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo.
Rudling, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41615-3 · Cited by 117
Regulation of intracellular actin polymerization by prenylated cellular proteins
Fenton, R., Kung, H., Longo, D., & Smith, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.2.347 · Cited by 117
Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond
Zeki, A. A., Franzi, L. M., Last, J. A., & Kenyon, N. J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0018oc · Cited by 119
Mechanisms of bone anabolism regulated by statins
Ruan, F., Zheng, Q., & Wang, J. (2012) · Bioscience Reports · doi:10.1042/bsr20110118 · Cited by 129
Malhotra, K., Subramani, M., Rawat, K., Kalamuddin, M., Qureshi, M. I., Malhotra, P., Mohmmed, A., Cornish, K., Daniell, H., & Kumar, S. B. (2016) · Molecular Plant · doi:10.1016/j.molp.2016.09.013 · Cited by 120
“However, the synthesis of IPP by the MEV pathway is tightly regulated due to its need to supply diverse metabolic processes (Goldstein and Brown, 1990).”
BackgroundCantini, L., Pecci, F., Hurkmans, D. P., Belderbos, R. A., Lanese, A., Copparoni, C., Aerts, S., Cornelissen, R., Dumoulin, D. W., Fiordoliva, I., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2020.10.031 · Cited by 115
Pulfer, M. K., & Murphy, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403581200 · Cited by 115
McMahon, M. A., Hahn, B. H., & Skaggs, B. J. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.98 · Cited by 134
Stulnig, T. M., Berger, M., Sigmund, T., Stockinger, H., Hořejšı́, V., & Waldhäusl, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19242 · Cited by 116
Chrissobolis, S., & Sobey, C. G. (2001) · Circulation Research · doi:10.1161/hh0801.090441 · Cited by 115
Elens, L., Becker, M. L., Haufroid, V., Hofman, A., Visser, L. E., Uitterlinden, A. G., Stricker, B. C., & van Schaik, R. H. N. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834c6edb · Cited by 114
Wang, B., Jakus, A. E., Baptista, P. M., Soker, S., Soto-Gutierrez, A., Abecassis, M. M., Shah, R. N., & Wertheim, J. A. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0235 · Cited by 113
Lytras, T., Nikolopoulos, G., & Bonovas, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1858 · Cited by 127
Lange, Y., & Steck, T. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13103 · Cited by 105
Effects of Statins on Skeletal Muscle: A Perspective for Physical Therapists
Di Stasi, S. L., MacLeod, T. D., Winters, J. D., & Binder-Macleod, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090251 · Cited by 114
Lopez, D., & McLean, M. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7220 · Cited by 110
Molecular basis of statin-associated myopathy
Vaklavas, C., Chatzizisis, Y. S., Ziakas, A., Zamboulis, C., & Giannoglou, G. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.021 · Cited by 128
Farnesyl-diphosphate synthase is localized in peroxisomes.
Krisans, S. K., Ericsson, J., Edwards, P. A., & Keller, G. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36769-8 · Cited by 114
Duncan, R. E., El-Sohemy, A., & Archer, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400732200 · Cited by 113
Kim, S. T., Kang, J. H., Lee, J., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Hwang, I. G., Lee, S., Park, K. W., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.08.005 · Cited by 118
“Mevalonatederived prenyl groups, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), facilitate essential intracellular functions of various proteins [8–10].”
BackgroundDependence of Ypt1 and Sec4 membrane attachment on Bet2
Rossi, G., Jiang, Y., Newman, A. P., & Ferro‐Novick, S. (1991) · Nature · doi:10.1038/351158a0 · Cited by 113
Spady, D. K., Cuthbert, J. A., Willard, M. N., & Meidell, R. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118113 · Cited by 114
“Presumably, accelerated conversion of cholesterol to bile acids causes depletion of a regulatory pool of unesterified cholesterol resulting in induction of sterol-regulated genes such as HMGCoAreductase and the LDL receptor (42, 43).”
BackgroundMarcus, S., Caldwell, G. A., Miller, D., Xue, C. B., Naider, F., & Becker, J. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3603 · Cited by 113
Langsjoen, P. H., & Langsjoen, A. M. (2003) · BioFactors · doi:10.1002/biof.5520180212 · Cited by 112
“As such, HMG CoA reductase inhibitors block the cellular production of both cholesterol and of coenzyme Q 10 [23,59].”
BackgroundMcGregor, G. H., Campbell, A. D., Fey, S. K., Tumanov, S., Sumpton, D., Blanco, G. R., Mackay, G., Nixon, C., Vazquez, A., Sansom, O. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0644 · Cited by 113
“Cholesterol is arguably the best studied product of the mevalonate pathway, and is an important lipid that acts as a structural component of mammalian cell membranes and a precursor for the synthesis of steroid hormones, bile acid, and vitamin D (3).”
BackgroundYuan, Y., Li, P., Li, J., Zhao, Q., Chang, Y., & He, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01759-7 · Cited by 132
“For example, GGPPS is a key enzyme in the mevalonate pathway catalysing the synthesis of GGPP from FPP. 283,284 Knocking down or pharmacologically inhibiting GGPPS results in reduced GGPP synthesis, and excess farnesyl pyrophosphate (FPP) can enhance the farnesylation of Rheb, which in turn overactivates mTORC1 signal…”
BackgroundInfluentialParnell, J. A., & Reimer, R. A. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993539 · Cited by 112
“Firstly, an increase in the expression of HMG-CoA reductase, an enzyme that regulates the conversion of HMG-CoA to mevalonate, the rate-limiting step in cholesterol synthesis((26)), was increased with prebiotic fibre.”
BackgroundHarris, I. R., Farrell, A. M., Grünfeld, C., Holleran, W. M., Elias, P. M., & Feingold, K. R. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12340962 · Cited by 112
Mehra, M. R., Uber, P. A., Vivekananthan, K., Solis, S., Scott, R. L., Park, M., Milani, R. V., & Lavie, C. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02340-9 · Cited by 112
“Two of these downstream products, farnesyl pyrophosphate and geranylgeranyl pyrophosphate, are the lipid moieties that can modulate the function of certain essential signaling proteins that influence smooth muscle cells and generation of nitric oxide (NO) (7).”
BackgroundLange, Y., Ye, J., & Strebel, F. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39867-9 · Cited by 113
Monoterpenes in breast cancer chemoprevention
Crowell, P. L. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005939806591 · Cited by 112
HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
Hess, D. C., Demchuk, A. M., Brass, L. M., & Yatsu, F. M. (2000) · Neurology · doi:10.1212/wnl.54.4.790 · Cited by 128
Receptor-mediated mechanisms of peroxisome proliferators
Green, S. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90554-v · Cited by 112
Marseille‐Tremblay, C., Éthier‐Chiasson, M., Forest, J., Giguère, Y., Masse, A., Mounier, C., & Lafond, J. (2007) · Molecular Reproduction and Development · doi:10.1002/mrd.20842 · Cited by 122
“The rate-limiting step for cholesterol synthesis is catalyzed by the HMG-CoA reductase (HMGR), an endoplasmic reticulum (ER) enzyme that produces mevalonate from acetate (Goldstein and Brown, 1990).”
Das, A., Goldstein, J. L., Anderson, D. D., Brown, M. S., & Radhakrishnan, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309273110 · Cited by 120
“We included a small amount of mevalonate to maintain the supply of nonsterol products of HMG CoA reductase (21).”
BackgroundSelf-citation
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.